Expression of Concern
This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.
This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.
Research Paper Volume 12, Issue 19 pp 19585—19596
Glypican-1-targeted and gemcitabine-loaded liposomes enhance tumor-suppressing effect on pancreatic cancer
Figure 5. GPC1-LP (GEM) inhibited tumor growth of the orthotopic pancreatic cancer mice. (A) The weight changes of the orthotopic pancreatic cancer mice treated with saline (control), LP, GPC1-LP, GEM, LP (GEM) and GPC1-LP (GEM). (B) The tumor weight of the orthotopic pancreatic cancer mice treated with saline (control), LP, GPC1-LP, GEM, LP (GEM) and GPC1-LP (GEM). (C) The correlation between GPC1 mRNA and hypoxia in pancreatic cancer was detected by TCGA database. (D) qRT-PCR was used to detect mRNA expression levels of tumor tissues and genes associated with hypoxia. *p<0.05.